InsidersTradesSigma
Devyser Diagnostics AB Stock: price and insider trades · Finland · FIN-FSA
Track the Devyser Diagnostics AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Devyser Diagnostics AB has logged 5 public disclosures. Market capitalisation: €1.5bn. The latest transaction was filed on 20 March 2026 (Purchase). Among the most active insiders: Mia Arnhult. The full history is accessible without an account.
5
Insider Decl.
0
Thresholds
€99,264
3 ops.
Buy Volume
·
0 ops.
Sell Volume
36Σ signal
Fundamental score
Ranked 19,474 of 25,899 companies
34.5
score / 100
Value18
Quality51
FCF yld-6.0%
Earn yld-0.8%
EV/EBITDA39.5x
ROE4.4%
Gross mgn81%
Net mgn-3.4%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 March 2026
Declarations5 total
500 shares@ €7.14810.0002% mcap0.5% of flowAktieFI:A003X205-1
Ideal exit: 15 Dec 2026 (T+270)
9,802 shares@ €9.26120.0060% mcap12.4% of flowAktieFI:A003W323-1
3,000 shares@ €9.45770.0019% mcap100.0% of flowAktieFI:A003W255-1
Ideal exit: 15 Nov 2026 (T+270)
41,596 shares@ €13.68960.038% mcap77.9% of flowAktieFI:A003S223-1
7,000 shares@ €9.61670.0045% mcap9.2% of flowAktieFI:A003M659-1
Ideal exit: 9 Dec 2025 (T+270)
5 of 5 declarations